Dicot Pharma AB: Dicot Pharma completes tablet manufacturing ahead of phase 2b clinical study

Uppsala, Sweden, May 20, 2026. Dicot Pharma AB announces that the company has successfully completed manufacturing of the drug candidate LIB-01 as a tablet for the planned phase 2b study, which is int ...

Dicot Pharma AB: Dicot Pharma publishes prospectus in connection with the forthcoming rights issue

Dicot Pharma AB ("Dicot Pharma" or the "Company") today, on May 19, 2026, publishes an EU Follow-on Prospectus (the "Prospectus") in connection with the rights issue of units, consisting of shares and ...
Hosted on MSN

Treating monocot plants from caterpillar damage

David Whitwam with Whitwam Organics demonstrated the importance of natural pesticides when it comes to corn and other monocot plants. Takeaways from Indiana, Ohio and Michigan primaries Medicare data ...
Investopedia

ETF vs. Mutual Fund: What's the Difference?

Christina Majaski writes and edits finance, credit cards, and travel content. She has 14+ years of experience with print and digital publications. Americans have over $30 trillion invested in mutual ...